Method for fabrication of additively manufactured, self-gelling structures and their use
US-2024245836-A1 · Jul 25, 2024 · US
Injectable hydrogel implant for treating glaucoma
US9205181B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9205181-B2 |
| Application number | US-201514590428-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 6, 2015 |
| Priority date | Jan 9, 2014 |
| Publication date | Dec 8, 2015 |
| Grant date | Dec 8, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A method is provided for increasing the aqueous outflow of fluid through a trabecular meshwork and into a Schlemm's canal of an eye. A liquid hydrogel precursor solution is introduced into the Schlemm's canal, during a medical procedure. The liquid hydrogel precursor solution is crosslinked to form a water-permeable flexible semi-solid hydrogel in the Schlemm's canal, during the medical procedure. The hydrogel is left in the Schlemm's canal upon conclusion of the medical procedure. Other embodiments are also described.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for increasing the aqueous outflow of fluid through a trabecular meshwork and into a Schlemm's canal of an eye, the method comprising: introducing a liquid hydrogel precursor solution into the Schlemm's canal, during a medical procedure; crosslinking the liquid hydrogel precursor solution to form a water-permeable flexible semi-solid hydrogel in the Schlemm's canal, during the medical procedure; and leaving the hydrogel in the Schlemm's ca…
Assignees
Inventors
Classifications
- A61L31/145Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9205181B2 cover?
- A method is provided for increasing the aqueous outflow of fluid through a trabecular meshwork and into a Schlemm's canal of an eye. A liquid hydrogel precursor solution is introduced into the Schlemm's canal, during a medical procedure. The liquid hydrogel precursor solution is crosslinked to form a water-permeable flexible semi-solid hydrogel in the Schlemm's canal, during the medical procedu…
- Who is the assignee on this patent?
- Rainbow Medical Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61L31/145. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).